Liberate Medical
Medical Device
Crestwood, KY 1,148 followers
Helping Patients Take Their Next Breath
About us
Liberate Medical is a medical device company that develops neuromuscular electrical stimulation technology to improve the quality and reduce the cost of care for patients with pulmonary disorders. Liberate's lead product, the VentFree™ respiratory muscle stimulator. Invasive mechanical ventilation commonly weakens the breathing muscles, increasing the need for further ventilator support. VentFree applies proprietary, non-invasive, electrical stimulation to the expiratory muscles in synchrony with exhalation while a patient is on mechanical ventilation. This breakthrough therapy, which is quick and simple to use, is intended to reduce abdominal muscle atrophy and the time taken to liberate patients from mechanical ventilation. Reduced days on mechanical ventilation can potentially lead to reduced morbidity and mortality, improved quality of life, and considerable savings for the health care provider.
- Website
-
http://www.liberatemedical.com
External link for Liberate Medical
- Industry
- Medical Device
- Company size
- 2-10 employees
- Headquarters
- Crestwood, KY
- Type
- Privately Held
- Founded
- 2013
Locations
-
Primary
Get directions
6400 Westwind Way
Suite A
Crestwood, KY 40014, US
Employees at Liberate Medical
-
John Marshall Moore
Entrepreneur
-
R. Michael Schotzinger, PhD
Medical Device Venture Capital | Senior Associate at SHD
-
Anuj Agarwal
Director of Engineering Research at Liberate Medical LLC
-
Euan J. McCaughey
A/Director of Research- Queen Elizabeth National Spinal Injuries Unit at NHS Greater Glasgow and Clyde
Updates
-
Liberate Medical reposted this
A/Director of Research- Queen Elizabeth National Spinal Injuries Unit at NHS Greater Glasgow and Clyde
Are you a spinal cord injury specialist working in an American rehabilitation or spinal cord injury centre. Do you have an interest in using electrical stimulation to improve respiratory function during inpatient rehabilitation? Our team at Liberate Medical are looking for sites to join us in a clinical trial investigating the role of Abdominal Functional Electrical Stimulation in improving cough for people during inpatient rehabilitation after SCI. If you would like to hear more about this trial please reach out.
-
-
We’re excited to be exhibiting at the American Thoracic Society (ATS) 2025 in San Francisco! Visit us at the Clinical Trials Exhibit – Booth CT-10 (Moscone South) to learn more about the PREVENT study and how the VentFree respiratory muscle stimulator is aiming to shorten mechanical ventilation from day one. We’ll be here Sunday through Tuesday — stop by and say hello. #ATS2025 #ClinicalTrials #Ventilation #CriticalCare #MedTech #LiberateMedical
-
-
We’re proud to share that Liberate Medical has been selected as a showcase company at the ATS 2025 Respiratory Innovation Summit in San Diego. Our CEO, Angus M., will be presenting on opening night—Friday, May 15—to an audience of leading investors, strategics, and innovators in pulmonary medicine. The Respiratory Innovation Summit is one of the premier global events connecting early-stage companies with key stakeholders shaping the future of respiratory care. We’re excited to highlight how VentFree, our non-invasive respiratory muscle stimulator, is helping patients wean from mechanical ventilation sooner and more safely. See more about the event here: https://lnkd.in/gaT_9QvC #ATS2025 #RespiratoryInnovation #MedTech #LiberateMedical #VentFree #PulmonaryCare #CriticalCareInnovation #StartupShowcase
-
-
Another productive and successful Investigator Meeting in the books — United States & Australia 🇺🇸🇦🇺 PREVENT 2025! Europe is next! 🌍 Huge thanks to all the amazing PIs, SCs, CRAs, and CROs who joined us (both in person and online) — your dedication and collaboration keep this study moving forward. 🙌 Let’s keep the momentum going! 🚀 #PREVENT #CriticalCareInnovation #medicaldevice #clinicalresearch
-
-
We're happy to share that our VentFree stimulator and the PREVENT study were recently featured in Pulse Magazine. The article offers an accessible overview of VentFree, highlighting its potential to positively impact clinical outcomes and reduce healthcare costs. As highlighted in the piece, Radboudumc has been incorporating VentFree into clinical care for several years and recently began patient screening for enrollment in our pivotal PREVENT trial. A big thank you to Leo Heunks for crafting this clear and insightful article. We also extend our gratitude to Leo, Tim Frenzel, and the entire team at Radboudumc for their ongoing support and valuable collaboration. Learn more about the VentFree stimulator and the PREVENT trial here: www.thepreventtrial.com Original article: https://lnkd.in/gnp-huuX #medicaldevices #innovation #ICU #mechanicalventilation